Global Peripheral Arterial Disease (PAD) Therapeutics Market 2020 to Witness Huge Growth by 2026 | Top Key Players; AstraZeneca Plc. (UK), Bayer HealthCare Pharmaceuticals (Germany), Bristol-Myers Squibb Company (US), Merck Co. Inc. (US), Proteon Therapeutics Inc. (US), Sanofi SA (France), Symic Bio Inc. (US) - Owned
[unable to retrieve full-text content] NAVIGATING THE SILENCE: RECONSIDERING TREATMENT PARADIGMS IN ASYMPTOMATIC SEVERE AORTIC STENOSIS ScienceDirect.com
[unable to retrieve full-text content] High arrhythmic risk in antero-septal acute myocardial ischemia is explained by increased transmural reentry occurrence | Scientific Reports Nature
Comments
Post a Comment